Latest Operational Efficiency News

InteliCare has locked in its largest-ever $8.8 million contract with mecwacare to deploy its AI-driven platform across 22 aged care homes, while appointing Angus Cameron as CEO to spearhead growth.

Mesoblast Limited posted US$30.3 million in net revenues for Ryoncil® in Q3 2026, hitting key clinical milestones and securing new technology licenses that could boost its next-generation cell therapies.

archTIS delivered a 231% year-on-year increase in annual recurring revenue to A$15.1 million, marked by the full deployment of its US Department of Defense custom software and a significant contract with a US-European military alliance.

IMEXHS Limited kicked off FY26 with a 13% revenue increase and a strategic pivot to an AI-native radiology workflow platform, securing major contracts in Latin America and advancing proprietary AI agents.

Beonic Limited’s Q3 FY26 results highlight a tripling of EBITDA margin to 15.8%, driven by operational leverage and gross margin expansion, while the Moroccan Airports rollout stays on track for full delivery by June 2026.

Atomic Eagle Limited has boosted its Muntanga Uranium Project resources by 24%, declared a maiden Ore Reserve, and confirmed project viability through an independent engineering review, setting the stage for a major drilling campaign.

Kingsgate Consolidated sustained robust production at Chatree with a fifth straight quarter exceeding 20,000 ounces of gold, while achieving a record AISC margin and boosting cash reserves to A$213 million.

Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.

Regis Healthcare expects FY26 underlying EBITDA of approximately $135 million, buoyed by near-record occupancy and a disciplined capital strategy amid evolving government reforms.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Metals X reported its fourth highest quarterly tin production at Renison with robust financials despite rising unit costs, while progressing the Rentails project and maintaining a strong cash position.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.